- Home
- LIQT vs INAB Comparison
LIQT vs INAB Comparison
Compare LIQT & INAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIQT
- INAB
- Stock Information
- Founded
- LIQT 2004
- INAB 2016
- Country
- LIQT Denmark
- INAB United States
- Employees
- LIQT N/A
- INAB N/A
- Industry
- LIQT Industrial Machinery/Components
- INAB Biotechnology: Pharmaceutical Preparations
- Sector
- LIQT Technology
- INAB Health Care
- Exchange
- LIQT Nasdaq
- INAB Nasdaq
- Market Cap
- LIQT 16.9M
- INAB 14.5M
- IPO Year
- LIQT N/A
- INAB 2021
- Fundamental
- Price
- LIQT $1.61
- INAB $4.17
- Analyst Decision
- LIQT Strong Buy
- INAB Strong Buy
- Analyst Count
- LIQT 2
- INAB 2
- Target Price
- LIQT $4.70
- INAB $3.60
- AVG Volume (30 Days)
- LIQT 16.2K
- INAB 7.9M
- Earning Date
- LIQT 05-14-2025
- INAB 05-07-2025
- Dividend Yield
- LIQT N/A
- INAB N/A
- EPS Growth
- LIQT N/A
- INAB N/A
- EPS
- LIQT N/A
- INAB N/A
- Revenue
- LIQT $14,986,815.00
- INAB N/A
- Revenue This Year
- LIQT $32.70
- INAB N/A
- Revenue Next Year
- LIQT $15.79
- INAB N/A
- P/E Ratio
- LIQT N/A
- INAB N/A
- Revenue Growth
- LIQT N/A
- INAB N/A
- 52 Week Low
- LIQT $1.34
- INAB $0.10
- 52 Week High
- LIQT $3.20
- INAB $4.17
- Technical
- Relative Strength Index (RSI)
- LIQT 50.37
- INAB 98.72
- Support Level
- LIQT $1.48
- INAB $0.10
- Resistance Level
- LIQT $1.79
- INAB $0.19
- Average True Range (ATR)
- LIQT 0.09
- INAB 0.11
- MACD
- LIQT 0.00
- INAB 0.26
- Stochastic Oscillator
- LIQT 31.43
- INAB 100.00
About LIQT LiqTech International Inc.
LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in three businesses that are diesel particulate filters (DPF) for the control of soot from diesel engines, turnkey ceramic membranes systems, and complete water treatment plants. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and kiln furniture. Its operating segment includes Water, Ceramics, and Plastics.
About INAB IN8bio Inc.
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.